Skip to content
StockMarketAgent
Healthcare / Medical - PharmaceuticalsUpdated 2026-05-10 22:07 UTC

LON/0KF3 stock hub

LON/0KF3 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

LON/0KF3is not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
24.1M
London Stock Exchange
Market data

Live price

Current market quote for this ticker.

Current price
LON/0KF3
In the news

Latest news · LON/0KF3

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 12.9P50 16.9P75 23.5
Trailing P/En/a
P25 15.9P50 22.9P75 35.8
ROE-378.7
P25 -54.2P50 2.1P75 13.7
ROIC-269.8
P25 -38.1P50 3.3P75 11.9
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All LON/0KF3 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
171
Groups with data
11
Currency
USD
Showing 171 of 171 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

20
MetricValue
Country
United States
Country code
UK
Employees
29
Employees Change
-1%
Employees Change Percent
-3.33
Enterprise value
$13.7M
Exchange
London Stock Exchange
Financial currency
USD
First seen
2026-05-10
Industry
Medical - Pharmaceuticals
Isin
US6960776010
Last refreshed
2026-05-10
Market cap
$24.1M
Price
$18.5
Price currency
USD
Rev Per Employee
229,653.24x
Sector
Healthcare
Sic
2836
Symbol
lon/0KF3
Website
https://palatin.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

7
MetricValue
Earnings Yield
-29.73%
EV Earnings
-1.91x
EV/FCF
-1.16x
EV/Sales
2.08x
FCF yield
-49.04%
P/B ratio
2.82x
P/S ratio
3.61x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

14
MetricValue
EBIT Margin
-139.45%
EBITDA Margin
-137.94%
Gross margin
-40.24%
Gross Profit
$-2.7M
Net Income
$-7.2M
Net Income Growth Years
1%
Pretax Margin
-107.41%
Profit Margin
-107.41%
Profit Per Employee
$-246,664
ROA
-70.26
Roa5y
-96.28
ROCE
-107.8
ROE
-378.7
ROIC
-269.8

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

7
MetricValue
Cagr1y
290.5%
Cagr3y
-45.56%
Cagr5y
-51.74%
EPS Growth Years
0
Revenue Growth
2,461.03x
Revenue Growth Years
0x
Revenue Growth3 Y
45.95x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

20
MetricValue
Asset Turnover
$0.81
Assets
$13.3M
Cash
$10.8M
Current Assets
$12.8M
Current Liabilities
$4.6M
Debt
$259,149
Debt Equity
$0.03
Debt FCF
$-0.02
Equity
$8.5M
Interest Coverage
-1,606.2
Liabilities
$4.8M
Long Term Assets
$507,662
Long Term Liabilities
$155,964
Net Cash
$10.5M
Net Cash By Market Cap
$43.63
Net Cash Growth
361.85%
Net Debt Equity
$-1.23
Tangible Book Value
$8.5M
Tangible Book Value Per Share
$4.85
WACC
3.74

Liquidity

Current-asset coverage and working-capital efficiency metrics.

5
MetricValue
Current ratio
2.76
Net Working Capital
$-2.3M
Quick ratio
2.54
Working Capital
$8.3M
Working Capital Turnover
$2.54

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

1
MetricValue
Buyback Yield
-232.53%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

37
MetricValue
1Y total return
290.13%
200-day SMA
23.18
3Y total return
-83.88%
50-day SMA
20.28
50-day SMA vs 200-day SMA
50under200
5Y total return
-97.38%
All Time High
1,812.5
All Time High Change
-98.98%
All Time High Date
2018-04-13
All Time Low
3.67
All Time Low Change
404.09%
All Time Low Date
2025-05-07
ATR
1.84
Beta
-0.09
Beta1y
-2.42
Beta2y
-1.32
Ch YTD
-33.24
High
20.4
High52
27.71
High52 Date
2025-12-11
High52ch
-33.24%
Low
18.5
Low52
4.11
Low52 Date
2025-05-09
Low52ch
404.09%
Ma50ch
-8.79%
Price vs 200-day SMA
-20.2%
RSI
44.86
RSI Monthly
37.48
RSI Weekly
44.79
Sharpe ratio
0.41x
Sortino ratio
0.79
Total Return
-232.53%
Tr YTD
-33.24
Tr1m
-4.64%
Tr1w
-15.53%
Tr3m
8.82%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

2
MetricValue
Operating Income
$-9.3M
Operating margin
-139.4

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

6
MetricValue
Float
1,262,132%
Shares Insiders
9.08%
Shares Institutions
33.88%
Shares Out
1,772,199
Shares Qo Q
131.19%
Shares Yo Y
232.53%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

52
MetricValue
Adjusted FCF
$-12.7M
Average Volume
10.15x
Bv Per Share
4.85
CAPEX
$-9,522
Ch1m
-4.64
Ch1w
-15.53
Ch1y
290.1
Ch3m
8.82
Ch3y
-83.88
Ch5y
-97.38
Ch6m
184.6
Change
-1.49%
Change From Open
-5.32
Close
18.78
Days Gap
4.05
Depreciation Amortization
99,077.2
Dollar Volume
55.5
Earnings Date
2026-05-14
EBIT
$-9.3M
EBITDA
$-9.2M
EPS
$-5.89
F Score
3
FCF
$-11.8M
FCF EV Yield
-86.18x
FCF Per Share
$-6.66
Financing CF
19,549,756
Fiscal Year End
June
Founded
1,986
Investing CF
458,568
Is Primary Listing
1
Last Earnings Date
2026-02-13
Last Report Date
2025-12-31
Last Split Date
2025-08-12
Last Split Type
Reverse
Ma150
14.75
Ma150ch
25.43%
Ma20
20.39
Ma20ch
-9.25%
Net CF
8,217,252
Next Earnings Date
2026-05-14
Open
19.54
Position In Range
0
Ppne
337,599.1
Price Date
2026-05-08
Ptbv Ratio
2.82
Relative Volume
0.3x
Revenue
6,659,944x
SBC By Revenue
12.97x
Share Based Comp
863,926
Tr6m
184.62%
Volume
3
Z Score
-35.84
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does LON/0KF3 pay a dividend?

Capital-return profile for this ticker.

Performance

LON/0KF3 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+290.1%
S&P 500 1Y: n/a
3Y total return
-83.9%
S&P 500 3Y: n/a
5Y total return
-97.4%
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns LON/0KF3?

Insider, institutional, and short-interest positioning.

Institutional ownership
+33.9%
Share of float held by funds and institutions
Insider ownership
+9.1%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
+232.5%
Negative means the company is buying back shares.
Technical

LON/0KF3 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
44.9
Neutral momentum band
Price vs 200-day MA
-20.2%
50/200-day relationship not available
Beta (5Y)
-0.09
Less volatile than the market
Sharpe ratio
0.41
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About LON/0KF3

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/0KF3 stock rating?

lon/0KF3 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/0KF3 analysis?

The full report lives at /stocks/lon/0KF3/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/0KF3?

The latest report frames lon/0KF3 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/0KF3 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.

lon/0KF3 stock profile: metrics, valuation and analysis | เอเจนต์ AI ตลาดหุ้น